MucoLife to Attend JP Morgan Healthcare Week 2026

MucoLife Therapeutics will attend JP Morgan Healthcare Week in San Francisco, January 12–15, 2026, as part of Business Sweden’s Team Sweden delegation.

JP Morgan Healthcare Week is the world’s leading gathering for life science investors, pharmaceutical companies, and strategic partners. During the week, MucoLife CEO, Thaher Pelaseyed, will engage with investors and industry partners to discuss its first-in-class inhaled therapy, MLT-001, for the treatment of pulmonary mucus obstruction in diseases such as COPD, cystic fibrosis, and bronchiectasis.

Investors and potential partners interested in meeting with MucoLife are encouraged to reach out to schedule a meeting.

For meeting inquiries, email tpelaseyed@mucolife.com.